CDXS
Price:
$2.57
Market Cap:
$233.60M
Codexis, Inc. is a biotechnology firm dedicated to the discovery, development, and commercialization of enzymes and other protein-based solutions. Its diverse portfolio encompasses advanced biocatalyst products and related services, specialized chemical intermediates vital for subsequent processing steps, and proprietary biocatalyst panels and kits that empower clients to conduct effective chemistry screening. The company also extends its expertise through biocatalyst screening and sophisticated protein engineering services. Central to its operations is the proprietary CodeEvolver protein engineering technology platform. This innovative platform is instrumental in crafting and delivering hig...[Read more]
Industry
Biotechnology
IPO Date
2010-04-22
Stock Exchange
NASDAQ
Ticker
CDXS
According to Codexis, Inc.’s latest financial reports and current stock price. The company's current ROE is -68.09%. This represents a change of 258.92% compared to the average of -18.97% of the last 4 quarters.
The mean historical ROE of Codexis, Inc. over the last ten years is -49.20%. The current -68.09% ROE has changed 38.40% with respect to the historical average. Over the past ten years (40 quarters), CDXS's ROE was at its highest in in the December 2025 quarter at 19.00%. The ROE was at its lowest in in the March 2017 quarter at -63.87%.
Average
-49.20%
Median
-34.00%
Minimum
-97.53%
Maximum
-11.31%
Discovering the peaks and valleys of Codexis, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 279.41%
Maximum Annual ROE = -11.31%
Minimum Annual Increase = -79.38%
Minimum Annual ROE = -97.53%
| Year | ROE | Change |
|---|---|---|
| 2025 | -87.03% | -10.77% |
| 2024 | -97.53% | 10.81% |
| 2023 | -88.02% | 279.41% |
| 2022 | -23.20% | 79.23% |
| 2021 | -12.94% | -8.30% |
| 2020 | -14.11% | 24.79% |
| 2019 | -11.31% | -41.45% |
| 2018 | -19.32% | -79.38% |
| 2017 | -93.68% | 109.07% |
| 2016 | -44.81% | 35.23% |
The current ROE of Codexis, Inc. (CDXS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-90.86%
5-year avg
-61.75%
10-year avg
-49.20%
Codexis, Inc.’s ROE is greater than OmniAb, Inc. (-20.31%), less than Sangamo Therapeutics, Inc. (6.69%), less than Insight Molecular Diagnostics Inc. (380.80%), greater than C4 Therapeutics, Inc. (-50.68%), greater than Rani Therapeutics Holdings, Inc. (-245.45%), less than Armata Pharmaceuticals, Inc. (162.59%), less than Innate Pharma S.A. (593.93%), greater than Genfit S.A. (-596.44%), greater than Protara Therapeutics, Inc. (-38.70%), greater than Invivyd, Inc. (-53.48%),
| Company | ROE | Market cap |
|---|---|---|
| -20.31% | $278.67M | |
| 6.69% | $70.43M | |
| 380.80% | $146.02M | |
| -50.68% | $343.73M | |
| -245.45% | $51.11M | |
| 162.59% | $259.91M | |
| 593.93% | $169.96M | |
| -596.44% | $445.68M | |
| -38.70% | $153.59M | |
| -53.48% | $128.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Codexis, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Codexis, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Codexis, Inc.'s ROE?
How is the ROE calculated for Codexis, Inc. (CDXS)?
What is the highest ROE for Codexis, Inc. (CDXS)?
What is the 3-year average ROE for Codexis, Inc. (CDXS)?
What is the 5-year average ROE for Codexis, Inc. (CDXS)?
How does the current ROE for Codexis, Inc. (CDXS) compare to its historical average?